HUTCHMED (China) Limited (HCM) — 分析师展望 / 分析师共识目标价为. 基于 10 位分析师评级, 共识为 看涨 — 8 买入, 1 持有, 1 卖出.
分析师共识目标价为 $17.50, 上涨空间为 15.1% 相对于当前价格 $15.21.
分析师预估 每股收益(EPS)为 $0.00 和 营收为 $0.09B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $0.20 vs 预期 $0.00 (超预期 +5764.6%). 2025: 实际 $2.65 vs 预期 $0.34 (超预期 +672.1%). 分析师准确度: 6%.
HCM 股票 — 12个月价格预测
$17.50
▲ +15.06% 上涨空间
平均目标价
Based on 10 Wall Street analysts offering 12-month price targets for HUTCHMED (China) Limited, the price target is $17.50.
平均目标价相对最新价格 $15.21 变动 +15.06%。
HCM 分析师评级
Buy
基于过去3个月内 10 位分析师对 HUTCHMED (China) Limited 的评级
EPS 预测 — HCM
6%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.20
vs Est –$0.00
▲ 101.8% off
2025
Actual $2.65
vs Est $0.34
▲ 87.0% off
Profitability Outlook
Company is profitable but with thin earnings per share. EPS trend is improving.
营收预测 — HCM
13%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.630B
vs Est $0.085B
▲ 86.5% off
2025
Actual $0.550B
vs Est $0.072B
▲ 86.9% off
Revenue Trend
Revenue has declined over the period shown. Analysts forecast significant revenue growth ahead.
